The Effect of Perioperative Dexamethasone on Postoperative Complications after Pancreaticoduodenectomy: A Multicenter Randomized Controlled Trial

H Chen, Y Wang, K Jiang, Z Xu, Y Jiang, Z Wu, X Lu… - 2024 - journals.lww.com
Objective: This study aimed to evaluate the effect of perioperative dexamethasone on
postoperative complications after pancreaticoduodenectomy. Background: The …

[HTML][HTML] The effect of perioperative of dexamethasone on postoperative complications after pancreaticoduodenectomy (PANDEX): a study protocol for a pragmatic …

H Chen, Y Wang, C Wang, X Lu, Y Li, B Sun, K Jiang… - Trials, 2023 - Springer
Background Pancreaticoduodenectomy (PD) nowadays serves as a standard treatment for
patients with disorders of the pancreas, intestine, and bile duct. Although the mortality rate of …

Intraoperative dexamethasone decreases infectious complications after pancreaticoduodenectomy and is associated with long-term survival in pancreatic cancer

M Sandini, KJ Ruscic, CR Ferrone, AL Warshaw… - Annals of Surgical …, 2018 - Springer
Background Dexamethasone is administered intraoperatively to prevent anesthesia-related
nausea and vomiting and to reduce postoperative opioid administration. However, the …

[HTML][HTML] Outcomes of peri-operative glucocorticosteroid use in major pancreatic resections: a systematic review

LL Kuan, AR Dennison, G Garcea - HPB, 2021 - Elsevier
Background There is increasing evidence that peri-operative glucocorticosteroid can
ameliorate the systemic response following major surgery. Preliminary evidence suggests …

Perioperative hydrocortisone reduces major complications after pancreaticoduodenectomy: a randomized controlled trial

M Laaninen, J Sand, I Nordback, K Vasama… - Annals of …, 2016 - journals.lww.com
Objectives: The aim of this study was to study whether post-pancreaticoduodenectomy
complications (PPDC) in high-risk patients can be reduced with hydrocortisone …

Impact of intraoperative dexamethasone on surgical and oncologic outcomes for patients with resected pancreatic ductal adenocarcinoma

TE Newhook, JM Soliz, LR Prakash… - Annals of surgical …, 2021 - Springer
Background Administration of dexamethasone to mitigate postoperative nausea and
vomiting has been suggested to improve short-and long-term outcomes after pancreatic …

Association between preoperative steroids and outcomes in patients undergoing pancreaticoduodenectomy using the national surgical quality improvement program

H Aziz, Z Ahmed, M Abdimajid, Y Sekigami… - Journal of …, 2022 - Springer
Background A national study analyzing the association between preoperative steroid use
and outcomes after pancreatic resections is lacking. The purpose of this study is to evaluate …

Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial

JM Dieleman, AP Nierich, PM Rosseel… - Jama, 2012 - jamanetwork.com
Context Prophylactic corticosteroids are often administered during cardiac surgery to
attenuate the inflammatory response to cardiopulmonary bypass and surgical trauma; …

Perioperative hydrocortisone treatment reduces postoperative pancreatic fistula rate after open distal pancreatectomy. A randomized placebo-controlled trial

A Antila, A Siiki, J Sand, J Laukkarinen - Pancreatology, 2019 - Elsevier
Background Postoperative pancreatic fistula (POPF) is the most common complication after
distal pancreatectomy (DP). In a recent RCT on pancreaticoduodenectomy (PD) …

Efficacy of preoperative dexamethasone in patients with laparoscopic cholecystectomy: a prospective randomized double-blind study

Y Fukami, M Terasaki, Y Okamoto, K Sakaguchi… - Journal of hepato-biliary …, 2009 - Springer
Abstract Background/Purpose Dexamethasone has been reported to reduce postoperative
nausea and vomiting (PONV) after laparoscopic cholecystectomy (LC). However, its effect …